Last Updated: November 9, 2026

Details for Patent: 10,918,516

« Back to Dashboard


Which drugs does patent 10,918,516 protect, and when does it expire?

Patent 10,918,516 protects MIUDELLA and is included in one NDA.

This patent has six patent family members in five countries.

Summary for Patent: 10,918,516
Title:Intrauterine device with controlled copper ion elution
Abstract:A method of manufacturing an intrauterine device (IUD) for contraception that has a desired copper elution rate is described. The method may involve selecting an elongate shape memory member comprising a first metal having a first galvanic potential, selecting at least one attachment member comprising a second metal having a second galvanic potential that is different from the first galvanic potential, attaching the attachment member(s) to the shape memory member, and shaping the shape memory member to form a frame of the intrauterine contraceptive device. The first metal and the second metal are specifically selected as materials for the shape memory member and the attachment member(s), in order to achieve the desired copper elution rate.
Inventor(s):Michael Tal, Bob H. Katz, Scott M. Russell
Assignee: Sebela Vlc Ltd
Application Number:US15/441,539
Patent Claim Types:
see list of patent claims
Use; Device;

Drugs Protected by US Patent 10,918,516

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sebela Womens Hlth MIUDELLA copper SYSTEM;INTRAUTERINE 218201-001 Feb 24, 2025 RX Yes Yes ⤷  Start Trial ⤷  Start Trial Y ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,918,516

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2014334932 ⤷  Start Trial
Canada 2926210 ⤷  Start Trial
European Patent Office 3057547 ⤷  Start Trial
Mexico 2016004563 ⤷  Start Trial
Mexico 2020001751 ⤷  Start Trial
World Intellectual Property Organization (WIPO) 2015057291 ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.